Sharon mates phd
WebbIntra-Cellular Therapies Inc是一家開發治療中樞神經系統疾病新藥的生物技術公司。該公司專註於小分子藥物的遞送和臨床開發，以滿足神經精神和神經疾病的需求。 WebbAcid Base, Electrolytes, Fluids Allergy and Clinical Immunology Anesthesiology Anticoagulation Art and Images in Psychiatry Bleeding and Transfusion Cardiology Caring for the Critically Ill Patient Challenges in Clinical Electrocardiography Clinical Challenge Clinical Decision Support Clinical Implications of Basic Neuroscience
Sharon mates phd
Did you know?
Webb8 juli 2024 · Sharon Mates Ph.D. et al Case Summary On 07/08/2024 John Solakfiled an Other lawsuit againstSharon Mates Ph D. This case was filed in New York County Courts, Supreme Court Civil Term located in Washington, New York. The case status is Pending - Other Pending. Case DetailsPartiesDocumentsDockets Case Details Case … WebbAs President, Chief Executive Officer and Chairman of Intra-Cellular Therapies (ITCI), Sharon Mates, PhD leads Intra-Cellular Therapies, a biopharmaceutical company …
Webb20 dec. 2024 · “Caplyta is the only medication approved by the FDA to treat depressive disorders associated with bipolar I or bipolar II as both monotherapy and adjunctive … WebbBoard of Directors Sharon Mates, PhD, Chairman, Founder, President & Chief Executive Officer, Intra-Cellular Therapies Christopher Alafi, PhD, General Partner, Alafi Capital Richard Lerner, MD, Institute Professor & Former …
Webb2 apr. 2024 · Sharon Mates, PhD Intra-Cellular Therapies recently announced the expansion of its central nervous system (CNS) pipeline with ITI-1284 ODT-SL, with plans … WebbBoard of Directors Sharon Mates, PhD, Chairman, Founder, President & Chief Executive Officer, Intra-Cellular Therapies Christopher Alafi, PhD, General Partner, Alafi Capital …
WebbChristoph U. Correll, MD1; Kimberly E Vanover, PhD2; Suresh Durgam, MD 2; Robert Davis, PhD ; William Rowe, MSN 2; Sharon Mates, PhD ; and Andrew Satlin, MD2 1Department …
Webb9 mars 2024 · Sharon Mates owns over 62,335 units of Intra-Cellular Therapies Inc stock worth over $63,410,335 and over the last 9 years he sold ITCI stock worth over … chugach pay stubsWebbIntra-Cellular Therapies高管资料，包括公司高管名单，及董事会、高级管理层成员的简历和个人资料。 chugach physical therapy anchorage alaskaWebbFrom 1989-1998 Dr. Mates was the President and a board member of North American Vaccine Inc. and its predecessor companies. She has served on several boards and … destiny 2 sunward ordealWebb“Our program now has confirmatory evidence of efficacy and a favorable safety and tolerability profile of lumateperone in bipolar depression; we look forward to submitting … chugack eareckson support servicesWebbDr. Sharon Mates Ph.D. Intra-Cellular Therapies Dr. Sharon Mates has been Chair, President, and CEO of ITI since June 2002, having co-founded the company in May of … chugach national forest sizeWebb20 okt. 1997 · RESUME Sharon Mates Title: President of Beltsville's North American Vaccine Inc. Born: New York City Age: 44 Education: Bachelor's of science degree from … destiny 2 sunshot ornamentWebb316 ABSTRACTS same population to test its efficacy in not just Pacific tolerance test (OGTT), hyperinsulinemic-euglycemic clamp, Islanders, but all youth chugach national park alaska